{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:42:00Z","timestamp":1778798520465,"version":"3.51.4"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T00:00:00Z","timestamp":1513641600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2017.00698","type":"journal-article","created":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T04:57:51Z","timestamp":1513659471000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":51,"title":["De novo Synthesis of Sphingolipids Is Defective in Experimental Models of Huntington's Disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Alba","family":"Di Pardo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Basit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Armirotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Amico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Castaldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Marracino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Buttari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna F.","family":"Digilio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Maglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,12,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"8606878","DOI":"10.1155\/2016\/8606878","article-title":"Sphingosine-1-phosphate signaling in immune cells and inflammation: roles and therapeutic potential","volume":"2016","author":"Aoki","year":"2016","journal-title":"Mediators Inflamm."},{"key":"B2","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1007\/s00216-015-8585-6","article-title":"Rapid evaluation of 25 key sphingolipids and phosphosphingolipids in human plasma by LC-MS\/MS","volume":"407","author":"Basit","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B4","doi-asserted-by":"publisher","first-page":"5467","DOI":"10.1074\/jbc.M805186200","article-title":"FTY720 inhibits ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells","volume":"284","author":"Berdyshev","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.bcp.2015.05.007","article-title":"Interference with distinct steps of sphingolipid synthesis and signaling attenuates proliferation of U87MG glioma cells","volume":"96","author":"Bernhart","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"a013326","DOI":"10.1101\/cshperspect.a013326","article-title":"Sphingolipid homeostasis in the endoplasmic reticulum and beyond","volume":"5","author":"Breslow","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1002\/art.27463","article-title":"Dihydrosphingosine 1-phosphate has a potent antifibrotic effect in scleroderma fibroblasts via normalization of phosphatase and tensin homolog levels","volume":"62","author":"Bu","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S1474-4422(15)00177-5","article-title":"Treating the whole body in Huntington's disease","volume":"14","author":"Carroll","year":"2015","journal-title":"Lancet Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1051\/medsci\/20143005006","article-title":"[Sphingosine 1-phosphate as a biomarker for Alzheimer's disease?]","volume":"30","author":"Ceccom","year":"","journal-title":"Med. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/2051-5960-2-12","article-title":"Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer's disease","volume":"2","author":"Ceccom","year":"","journal-title":"Acta Neuropathol. Commun."},{"key":"B11","first-page":"217","article-title":"Huntington's disease: the past, present, and future search for disease modifiers","volume":"86","author":"Clabough","year":"2013","journal-title":"Yale J. Biol. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2051-5960-2-9","article-title":"Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer's disease pathogenesis","volume":"2","author":"Couttas","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neurobiolaging.2016.03.027","article-title":"Loss of ceramide synthase 2 activity, necessary for myelin biosynthesis, precedes tau pathology in the cortical pathogenesis of Alzheimer's disease","volume":"43","author":"Couttas","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"B14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/85879","article-title":"Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I","volume":"27","author":"Dawkins","year":"2001","journal-title":"Nat. Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"14230","DOI":"10.1073\/pnas.1206093109","article-title":"Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome","volume":"109","author":"Deogracias","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.nbd.2007.05.003","article-title":"Glycolipid and ganglioside metabolism imbalances in Huntington's disease","volume":"27","author":"Desplats","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"5280","DOI":"10.1038\/s41598-017-05709-y","article-title":"Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease","volume":"7","author":"Di Pardo","year":"","journal-title":"Sci. Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1093\/hmg\/ddt615","article-title":"FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease","volume":"23","author":"Di Pardo","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3389\/fnins.2016.00457","article-title":"Impaired levels of gangliosides in the corpus callosum of Huntington disease animal models","volume":"10","author":"Di Pardo","year":"2016","journal-title":"Front. Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"41316","DOI":"10.1038\/srep41316","article-title":"Impairment of blood-brain barrier is an early event in R6\/2 mouse model of Huntington Disease","volume":"7","author":"Di Pardo","year":"","journal-title":"Sci. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1073\/pnas.1114502109","article-title":"Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice","volume":"109","author":"Di Pardo","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.bbr.2014.03.046","article-title":"Fingolimod increases brain-derived neurotrophic factor levels and ameliorates amyloid \u03b2-induced memory impairment","volume":"268","author":"Fukumoto","year":"2014","journal-title":"Behav. Brain Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4419-6741-1_1","article-title":"An overview of sphingolipid metabolism: from synthesis to breakdown","volume":"688","author":"Gault","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"41888","DOI":"10.1074\/jbc.M112.413500","article-title":"Ablation of neuronal ceramide synthase 1 in mice decreases ganglioside levels and expression of myelin-associated glycoprotein in oligodendrocytes","volume":"287","author":"Ginkel","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/BF02535859","article-title":"Effects of aging on the content, composition and synthesis of sphingomyelin in the central nervous system","volume":"27","author":"Giusto","year":"1992","journal-title":"Lipids"},{"key":"B26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.lfs.2013.07.017","article-title":"Inhibition of sphingosine-1-phosphate lyase rescues sphingosine kinase-1-knockout phenotype following murine cardiac arrest","volume":"93","author":"Gorshkova","year":"2013","journal-title":"Life Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.1176709","article-title":"Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate","volume":"325","author":"Hait","year":"2009","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nn.3728","article-title":"Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory","volume":"17","author":"Hait","year":"2014","journal-title":"Nat. Neurosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S1388-1981(03)00059-3","article-title":"Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism","volume":"1632","author":"Hanada","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0006-2952(00)00251-3","article-title":"Specificity of inhibitors of serine palmitoyltransferase (SPT), a key enzyme in sphingolipid biosynthesis, in intact cells. A novel evaluation system using an SPT-defective mammalian cell mutant","volume":"59","author":"Hanada","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"20681","DOI":"10.1038\/srep20681","article-title":"Metabolic disruption identified in the Huntington's disease transgenic sheep model","volume":"6","author":"Handley","year":"2016","journal-title":"Sci. Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.bbr.2013.06.016","article-title":"Neurorestorative effect of FTY720 in a rat model of Alzheimer's disease: comparison with memantine","volume":"252","author":"Hemmati","year":"2013","journal-title":"Behav. Brain Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.bbalip.2008.07.003","article-title":"The vascular S1P gradient-cellular sources and biological significance","volume":"1781","author":"Hla","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"B35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bbalip.2005.08.006","article-title":"Serine palmitoyl-CoA transferase (SPT) deficiency and sphingolipid levels in mice","volume":"1737","author":"Hojjati","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/nrendo.2014.19","article-title":"Bone: Key role for S1P in bone remodelling","volume":"11","author":"Holmes","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3390\/biom3030408","article-title":"Emerging role of sphingosine-1-phosphate in Inflammation, cancer, and Lymphangiogenesis","volume":"3","author":"Huang","year":"2013","journal-title":"Biomolecules"},{"key":"B38","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1083\/jcb.153.2.429","article-title":"Identification of a molecular target of psychosine and its role in globoid cell formation","volume":"153","author":"Im","year":"2001","journal-title":"J. Cell Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.brainres.2016.03.034","article-title":"Endoplasmic reticulum stress: the cause and solution to Huntington's disease?","volume":"1648","author":"Jiang","year":"2016","journal-title":"Brain Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"13713","DOI":"10.1523\/JNEUROSCI.1403-15.2015","article-title":"Substrate Availability of mutant SPT alters neuronal branching and growth cone dynamics in dorsal root ganglia","volume":"35","author":"Jun","year":"2015","journal-title":"J. Neurosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fnins.2017.00220","article-title":"Endoplasmic reticulum malfunction in the nervous system","volume":"11","author":"Jung","year":"2017","journal-title":"Front. Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.tibs.2013.05.003","article-title":"Huntington's disease: underlying molecular mechanisms and emerging concepts","volume":"38","author":"Labbadia","year":"2013","journal-title":"Trends Biochem. Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"CD009371","DOI":"10.1002\/14651858.CD009371.pub2","article-title":"Fingolimod for relapsing-remitting multiple sclerosis","volume":"4","author":"La Mantia","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"B44","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.mad.2005.09.011","article-title":"Huntingtin fragmentation and increased caspase 3, 8 and 9 activities in lymphoblasts with heterozygous and homozygous Huntington's disease mutation","volume":"127","author":"Maglione","year":"","journal-title":"Mech. Ageing Dev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neulet.2005.09.037","article-title":"The platelet maximum number of A2A-receptor binding sites (Bmax) linearly correlates with age at onset and CAG repeat expansion in Huntington's disease patients with predominant chorea","volume":"393","author":"Maglione","year":"","journal-title":"Neurosci. Lett."},{"key":"B46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/ajmg.b.30223","article-title":"Adenosine A2A receptor dysfunction correlates with age at onset anticipation in blood platelets of subjects with Huntington's disease","author":"Maglione","year":"2005","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"B47","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1523\/JNEUROSCI.6348-09.2010","article-title":"Impaired ganglioside metabolism in Huntington's disease and neuroprotective role of GM1","volume":"30","author":"Maglione","year":"2010","journal-title":"J. Neurosci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1242\/dev.094805","article-title":"Sphingosine 1-phosphate signalling","volume":"141","author":"Mendelson","year":"2014","journal-title":"Development"},{"key":"B49","doi-asserted-by":"publisher","first-page":"4958","DOI":"10.1093\/hmg\/ddv218","article-title":"Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation","volume":"24","author":"Miguez","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"B50","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1242\/dmm.013631","article-title":"Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy","volume":"7","author":"Nguyen-Tran","year":"2014","journal-title":"Dis. Model. Mech."},{"key":"B51","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/B978-0-12-381328-2.00013-4","article-title":"Huntington's disease: clinical presentation and treatment","volume":"98","author":"Novak","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41467-017-00353-6","article-title":"Identifying therapeutic targets by combining transcriptional data with ordinal clinical measurements","volume":"8","author":"Pirhaji","year":"2017","journal-title":"Nat. Commun."},{"key":"B53","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/nmeth.3940","article-title":"Revealing disease-associated pathways by network integration of untargeted metabolomics","volume":"13","author":"Pirhaji","year":"2016","journal-title":"Nat. Methods"},{"key":"B54","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1007\/s13311-016-0462-2","article-title":"Fingolimod: a disease-modifier drug in a mouse model of amyotrophic lateral sclerosis","volume":"13","author":"Potenza","year":"2016","journal-title":"Neurotherapeutics"},{"key":"B55","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1113\/eph8602216","article-title":"Impaired phospholipid-related signal transduction in advanced Huntington's disease","volume":"86","author":"Puri","year":"2001","journal-title":"Exp. Physiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"14134","DOI":"10.1074\/jbc.M109.076810","article-title":"Neurons and oligodendrocytes recycle sphingosine 1-phosphate to ceramide: significance for apoptosis and multiple sclerosis","volume":"285","author":"Qin","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B57","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2174\/156720506778249407","article-title":"Histone deacetylase inhibitors: a novel therapeutic approach to Huntington's disease (complex mechanism of neuronal death)","volume":"3","author":"Sadri-Vakili","year":"2006","journal-title":"Curr. Alzheimer Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"15371","DOI":"10.1074\/jbc.R115.653204","article-title":"Dihydroceramides: from bit players to lead actors","volume":"290","author":"Siddique","year":"2015","journal-title":"J. Biol. Chem."},{"key":"B59","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jbior.2014.09.002","article-title":"Regulation of de novo sphingolipid biosynthesis by the ORMDL proteins and sphingosine kinase-1","volume":"57","author":"Siow","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"B60","doi-asserted-by":"publisher","first-page":"43030","DOI":"10.1038\/srep43030","article-title":"Metabolic profiling of presymptomatic Huntington's disease sheep reveals novel biomarkers","volume":"7","author":"Skene","year":"2017","journal-title":"Sci. Rep."},{"key":"B61","doi-asserted-by":"publisher","first-page":"280","DOI":"10.2741\/4309","article-title":"Membrane lipid domains in the nervous system","volume":"20","author":"Sonnino","year":"2015","journal-title":"Front. Biosci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"5928","DOI":"10.1073\/pnas.1522071113","article-title":"Ectopic expression of ceramide synthase 2 in neurons suppresses neurodegeneration induced by ceramide synthase 1 deficiency","volume":"113","author":"Spassieva","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B63","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/ng1193-259","article-title":"Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues","volume":"5","author":"Strong","year":"1993","journal-title":"Nat. Genet."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e64050","DOI":"10.1371\/journal.pone.0064050","article-title":"FTY720\/fingolimod, a sphingosine analogue, reduces amyloid-\u03b2 production in neurons","volume":"8","author":"Takasugi","year":"2013","journal-title":"PLoS ONE"},{"key":"B65","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.tins.2011.06.005","article-title":"Emerging roles for cholesterol in Huntington's disease","volume":"34","author":"Valenza","year":"2011","journal-title":"Trends Neurosci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000362991","article-title":"Sphingosine-1-phosphate: boon and bane for the brain","volume":"34","author":"Van Echten-Deckert","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"key":"B67","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/ana.24170","article-title":"Impairment of ceramide synthesis causes a novel progressive myoclonus epilepsy","volume":"76","author":"Vanni","year":"2014","journal-title":"Ann. Neurol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"20811","DOI":"10.1074\/jbc.M116.744029","article-title":"FTY720\/fingolimod reduces synucleinopathy and improves gut motility in A53T Mice: CONTRIBUTIONS OF PRO-BRAIN-DERIVED NEUROTROPHIC FACTOR (PRO-BDNF) AND MATURE BDNF","volume":"291","author":"Vidal-Martinez","year":"2016","journal-title":"J. Biol. Chem."},{"key":"B69","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington's disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"B70","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-3-319-05879-5_4","article-title":"S1P control of endothelial integrity","volume":"378","author":"Xiong","year":"2014","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e1002063","DOI":"10.1371\/journal.pgen.1002063","article-title":"A deficiency of ceramide biosynthesis causes cerebellar purkinje cell neurodegeneration and lipofuscin accumulation","volume":"7","author":"Zhao","year":"2011","journal-title":"PLoS Genet."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnins.2017.00698\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T15:49:47Z","timestamp":1526399387000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnins.2017.00698\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,19]]},"references-count":71,"alternative-id":["10.3389\/fnins.2017.00698"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2017.00698","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,19]]},"article-number":"698"}}